A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, lethal malignancy that invades adjacent vasculatures and spreads to distant sites before clinical detection. Although invasion into the peripancreatic vasculature is one of the hallmarks of PDAC, paradoxically, PDAC tumors also exhibit hypovascularity. How PDAC tumors become hypovascular is poorly understood. We describe an organotypic PDAC-on-a-chip culture model that emulates vascular invasion and tumor-blood vessel interactions to better understand PDAC-vascular interactions. The model features a 3D matrix containing juxtaposed PDAC and perfusable endothelial lumens. PDAC cells invaded through intervening matrix, into vessel lumen, and ablated the endothelial cells, leaving behind tumor-filled luminal structures. Endothelial ablation was also observed in in vivo PDAC models. We also identified the activin-ALK7 pathway as a mediator of endothelial ablation by PDAC. This tumor-on-a-chip model provides an important in vitro platform for investigating the process of PDAC-driven endothelial ablation and may provide a mechanism for tumor hypovascularity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In another study, a biomimetic 3D organotypic model unveiled a mechanism by which pancreatic cancer cells induce endothelial ablation, resulting in tumor-driven endothelial cell death and hypoxia (Nguyen et al., 2019).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The study identified the activin-ALK7 signaling pathway as a key mediator of this endothelial ablation, suggesting a potential therapeutic strategy for pancreatic cancer by targeting this pathway.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Nguyen et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies have used CoC models to study and understand the effects of these cues on intravasation (Figure 3D-G).”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
In the citing paper
“Application of a chemotactic gradient of fetal bovine serum (FBS) around the blood vessel triggered the invasion of pancreatic cells, and the wrapping around the blood vessel prior to intravasation.”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citationInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363 · cited 1×
“INTRODUCTION Although the diagnosis and treatment of cancer in its earliest stages has substantially improved outcomes in many tumors, survival rates in patients with tumors that have spread to distant sites remain dismal (1).”
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
In vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“…the interactions between tumor cells with twodimensional (2D) planar or 3D vessel like structures have demonstrated the value of juxtaposing tumor cells with the vascular compartment, especially in the context of investigating extravasation and intrava sation properties ( 14 , 15 , 19 – 21 ).”
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
Self-citationLonardo, E., Hermann, P. C., Mueller, M.-T., Huber, S., Balic, A., Miranda-Lorenzo, I., Zagorac, S., Alcala, S., Rodriguez-Arabaolaza, I., Ramirez, J. C., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.10.001 · Cited by 405
In Vitro Perfused Human Capillary Networks
Moya, M. L., Hsu, Y.-H., Lee, A. P., Hughes, C. C. W., & George, S. C. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0430 · Cited by 387
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Wakefield, L. M., & Hill, C. S. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3500 · Cited by 374
Hypomethylation of pericentromeric DNA in breast adenocarcinomas
Narayan, A., Ji, W., Zhang, X.-Y., Marrogi, A., Graff, J. R., Baylin, S. B., & Ehrlich, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<833::aid-ijc6>3.0.co;2-v · Cited by 266
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Rhim, A. D., Thege, F. I., Santana, S. M., Lannin, T. B., Saha, T. N., Tsai, S., Maggs, L. R., Kochman, M. L., Ginsberg, G. G., Lieb, J. G., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.007 · Cited by 230
Self-citationPathways for aberrant angiogenesis in pancreatic cancer.
Korc, M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-8 · Cited by 196
A three-dimensional in vitro model of tumor cell intravasation
Ehsan, S. M., Welch-Reardon, K. M., Waterman, M. L., Hughes, C. C. W., & George, S. C. (2014) · Integrative Biology · doi:10.1039/c3ib40170g · Cited by 196
Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
Tuveson, D. A., & Neoptolemos, J. P. (2012) · Cell · doi:10.1016/j.cell.2011.12.021 · Cited by 188
Structural basis for the inhibition of activin signalling by follistatin
Harrington, A. E., Morris‐Triggs, S. A., Ruotolo, B. T., Robinson, C. V., Ohnuma, S., & Hyvönen, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601000 · Cited by 169 · cited 1×
“We then exposed PDAC cells to follistatin, a naturally occurring activin inhibitor ( 25 ), in our 2D patterned coculture and in our 3D organotypic model.”
Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion
Witz, C. A., Monotoya-Rodriguez, I. A., & Schenken, R. S. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00400-2 · Cited by 144
Genetically Engineered Mouse Models of Pancreatic Cancer
Westphalen, C. B., & Olive, K. P. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827ab4c4 · Cited by 139 · cited 1×
“To further strengthen our finding of endothelial ablation in PDAC in vivo, we sought to demonstrate the presence of blood vessels occupied by tumor cells in a genetically engineered mouse model (GEMM) of PDAC, in which many aspects of human tumor biology and progression are captured (22).”
Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
Davidowitz, R. A., Selfors, L. M., Iwanicki, M. P., Elias, K. M., Karst, A., Piao, H., Ince, T. A., Drage, M. G., Dering, J., Konecny, G. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69815 · Cited by 131
A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation
Lee, H., Park, W., Ryu, H., & Jeon, N. L. (2014) · Biomicrofluidics · doi:10.1063/1.4894595 · Cited by 130
Biomimetic Model of Tumor Microenvironment on Microfluidic Platform
Chung, M., Ahn, J., Son, K., Kim, S., & Jeon, N. L. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700196 · Cited by 126 · cited 1×
“…the interactions between tumor cells with twodimensional (2D) planar or 3D vessel like structures have demonstrated the value of juxtaposing tumor cells with the vascular compartment, especially in the context of investigating extravasation and intrava sation properties ( 14 , 15 , 19 – 21 ).”
Togashi, Y., Kogita, A., Sakamoto, H., Hayashi, H., Terashima, M., Velasco, M. A. D., Sakai, K., Fujita, Y., Tomida, S., Kitano, M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.037 · Cited by 98 · cited 1×
“In contrast, the role of activin in tumor progression has remained largely unappreciated, although activin levels in plasma have been associated with poor prognosis (38) and are overexpressed in multiple human pancreatic cancer cells (39).”
Imaging of pancreatic cancer: An overview.
Tummala, P., Junaidi, O., & Agarwal, B. (2011) · PubMed · doi:10.3978/j.issn.2078-6891.2011.036 · Cited by 94 · cited 1×
“…of tumor cells into the vasculature ( 8 – 10 ), followup in vivo studies in mice have not advanced our understanding of this phenomenon owing to the complexity of animal models ( 11 ) and challenges in spatiotemporal imaging of tumorvessel interactions in internal organs, such as pancreas ( 12 ).”
Role of nodal signaling and the microenvironment underlying melanoma plasticity
Postovit, L.-M. M., Margaryan, N. V., Seftor, E. A., & Hendrix, M. J. C. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00463.x · Cited by 63
Craven, K. E., Gore, J., & Korc, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.047 · Cited by 62 · cited 2×
“At the same time, tumor masses from these patients generally exhibit hypovascularity or a paucity of capillary vessels within these tumors (7).”
Kleeff, J., Ishiwata, T., Friess, H., Büchler, M. W., & Korc, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<860::aid-ijc11>3.0.co;2-5 · Cited by 61 · cited 1×
“In contrast, the role of activin in tumor progression has remained largely unappreciated, although activin levels in plasma have been associated with poor prognosis ( 38 ) and are overexpressed in multiple human pancreatic cancer cells ( 39 ).”
Hong, S., Goggins, M., Wolfgang, C. L., Schulick, R. D., Edil, B. H., Cameron, J. L., Handra‐Luca, A., Herman, J. M., & Hruban, R. H. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182376e36 · Cited by 56
Cell Competition During Growth and Regeneration
Gogna, R., Shee, K., & Moreno, E. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-055214 · Cited by 54 · cited 1×
“Perhaps, our observation of tumor endothelial cell ablation in PDAC fits a classical concept of cellcell competition, which describes clearance of “loser cells” by “winner cells” based on their fitness differences within the local environment such as their cellular divi sion potential (28).”
Biomimetic on-a-chip platforms for studying cancer metastasis
Lee, E., Song, H.-H. G., & Chen, C. S. (2016) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2015.12.001 · Cited by 49
Self-citationVascular invasion in pancreatic cancer: Tumor biology or tumor topography?
Rehders, A., Stoecklein, N. H., Güray, A., Riediger, R., Alexander, A., & Knoefel, W. T. (2012) · Surgery · doi:10.1016/j.surg.2012.05.012 · Cited by 47 · cited 1×
“The vast majority of patients once diagnosed with PDAC are already at the later stages of the disease (6).”
PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer
Li, J., Yang, Z., Zou, Q., Yuan, Y., Li, J., Liang, L., Zeng, G., & Chen, S. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1063-8 · Cited by 47
Xu, G., Zhou, H., Wang, Q., Auersperg, N., & Peng, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0174 · Cited by 47
Bandyopadhyay, S., Baştürk, O., Çoban, İ., Thirabanjasak, D., Liang, H., Altinel, D., & Adsay, V. N. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181908e42 · Cited by 44
Kim, B.-C., van Gelder, H., Kim, T. A., Lee, H.-J., Baik, K. G., Chun, H. H., Lee, D. A., Choi, K. S., & Kim, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313277200 · Cited by 42
Zeng, F., Xu, G., Zhou, T., Yang, C., Wang, X., Peng, C., & Zhou, H. (2011) · Medical Oncology · doi:10.1007/s12032-011-0114-7 · Cited by 13
Pancreatic adenocarcinoma and its mimickers: traps in diagnosis
Liang, H., Baştürk, O., Bandyopadhyay, S., Altinel, D., & Adsay, V. N. (2008) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2008.05.001 · Cited by 4 · cited 2×
“Al though a few histologic studies of patient samples have observed the extensive invasion of tumor cells into the vasculature ( 8 – 10 ), followup in vivo studies in mice have not advanced our understanding of this phenomenon owing to the complexity of animal models ( 11 ) and challenges in…”
Cited by
Organ-on-a-Chip: A New Paradigm for Drug Development
Ma, C., Peng, Y., Li, H., & Chen, W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.009 · Cited by 576
“An organotypic pancreatic cancer chip model (Figure 2a) was developed to investigate the interactions of pancreatic ductal adenocarcinoma (PDAC, a major exocrine pancreatic cancer) with the tumor vascular network, and the activin–ALK7 pathway identified to be the mechanism of PDAC hypovascularity, leading to poor drug…”
BackgroundOrgan-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
“The authors identified the activin-ALK7 pathway as a mediator of endothelial ablation by pancreatic ductal adenocarcinoma, which results in the limitation of the delivery of chemotherapeutic drugs to the tumors at later stages, and they replicated their findings in mice [137].”
BackgroundMicrofluidics for Drug Development: From Synthesis to Evaluation
Liu, Y., Sun, L., Zhang, H., Shang, L., & Zhao, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01289 · Cited by 202
Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications
Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 185
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems
Murray, B. O., Flores, C., Williams, C., Flusberg, D. A., Marr, E. E., Kwiatkowska, K. M., Charest, J. L., Isenberg, B. C., & Rohn, J. L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.691210 · Cited by 183
Metadata
- Authors
- Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S.
- Affiliations
- University of Pennsylvania (US)
- Boston University (US)
- Harvard University (US)
- Corresponding author
- Nguyen, Duc-Huy T.
- Lee, Esak
- Chen, Christopher S.
- ORCID
- Venue
- Science Advances
- Published
- 2019-08-02
- Volume
- 5
- Issue
- 8
- Pages
- eaav6789-eaav6789
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6713506
- OpenAlex
- W2970097127
- Cited by
- 172
- References
- 40
- Citations by year
- 2026: 8 · 2025: 30 · 2024: 28 · 2023: 26 · 2022: 25 · 2021: 27 · 2020: 26 · 2019: 2
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- OpenBU (Boston University) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health (EB00262, UH3EB017103, UC4DK104196)
- National Center for Advancing Translational Sciences (TL1TR001410)
- Lymphatic Education and Research Network (LE&RN Postdoctoral Fellowship)
- Harvard Ludwig Center
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor vascular invasion, tumor angiogenesis
- MeSH terms
- Adenocarcinoma, Animals, Cell Line, Humans, Neoplasm Invasiveness, Pancreatic Neoplasms, Signal Transduction, Carcinoma, Pancreatic Ductal, Activin Receptors, Type I, Biomimetics, Endothelial Cells, Cell Line, Tumor, Mice, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.